Taro Pharmaceuticals U.S.A., Inc.
FDA-inspected organization
Taro Pharmaceuticals U.S.A., Inc. has been audited by the FDA 15 times between 2000 and 2018 across all 1 sites.
Documents
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2014
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2013
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2009
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2008
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2007
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2006
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2004
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2004
Out of stock
FDA 483 Taro Pharmaceuticals U.S.A., Inc., Hawthorne | 2002
Out of stock
FDA Investigators (10)
- Tara K. Carmody, FDA Investigator
- Helen B. Ricalde, FDA Investigator
- Sony Mathews, FDA Investigator
- Demitria J. Xiradakis, FDA Investigator
- Paul C. Mouris, FDA Investigator
- Matthew A. Spataro, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Leena Thomas, FDA Investigator
- Perry T. Nichols, FDA Investigator
- Jacqueline S. Warner, FDA Investigator